Skip to content
Screener

CONMED CNMD General Surgery — Net Sales

Other product segments

Orthopedic Surgery
$152.32M+8.2%

Similar metrics at other companies

Baxter International logo
BAXAdvanced Surgery — Net Sales
$304M+13.4%
NN logo
NNBRGeneral Industrial — Net Sales
$31.33M+69.9%
Nature's Sunshine Products logo
NATRGeneral health — Net Sales
$48.9M+3.2%
Walmart logo
WMTGeneral merchandise — Net Sales
$29.07B+4.5%
AVN
AVNSEnteral feeding — Net Sales
$84.6M+13.6%
General Mills logo
GISPet — Net Sales
$746.6M+5.8%

Other financials

Income statement

See full
Revenue$343.5M+0.3%
Gross profit$197.5M+4.9%
Operating income$36.4M-4.6%
Net income$23.1M+7.7%
EPS (diluted)$0.77+11.6%

Balance sheet

See full
Cash & equivalents$37.3M+10.0%
Total debt$1.0B+14.5%
Total equity$1.0B+3.8%
Total assets$2.3B-1.2%

Cash flow

See full
Operating cash flow$37.1M+27.3%
CapEx$2.9M-48.8%
Free cash flow$34.2M+46.0%

Valuation

See full
Market cap$1.47B-9.4%
Enterprise value$2.45B-1.1%
P/E26×+11.3×
P/S1.1×-0.2×

Profitability

See full
Gross margin55.8%-0.3pp
Operating margin8%-5.0pp
Net margin4.1%-4.2pp
FCF margin9.8%-1.4pp

Returns & leverage

See full
Return on equity5.5%-6.2pp
Debt / equity+0.1×
Current ratio1.5×-0.7×

Where this comes from

Reported directly by CONMED in its filing.

Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.

The source filing: CONMED’s 10-Q, filed July 29, 2026.

Filed
Jul 29, 2026, 4:13 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0000816956-26-000102
Line itemThree Months Ended / June 30, 2026 / Orthopedic SurgeryThree Months Ended / June 30, 2026 / General SurgeryThree Months Ended / June 30, 2026 / TotalThree Months Ended / June 30, 2025 / Orthopedic SurgeryThree Months Ended / June 30, 2025 / General SurgeryThree Months Ended / June 30, 2025 / Total
Europe, Middle East & Africa40,30535,84276,14735,58832,18967,777
Asia Pacific36,56120,59657,15731,73620,34552,081
Americas (excluding the United States)23,79611,00334,79921,72310,15231,875
Total sales from contracts with customers$152,315$191,173$343,488$140,734$201,611$342,345
Timing of Revenue Recognition
Goods transferred at a point in time$139,852$188,205$328,057$129,382$199,065$328,447
Services transferred over time12,4632,96815,43111,3522,54613,898
Total sales from contracts with customers$152,315$191,173$343,488$140,734$201,611$342,345

Item 1. Financial Statements (unaudited)

FAQ

What is CONMED's general surgery — net sales?
CONMED (CNMD) reported general surgery — net sales of $191.17M in Q2 2026.
How has CONMED's general surgery — net sales changed year-over-year?
CONMED's general surgery — net sales decreased by 5.2% year-over-year, from $201.61M to $191.17M.
What is the long-term trend for CONMED's general surgery — net sales?
Over 4 years (2021 to 2025), CONMED's general surgery — net sales has grown at a 8.7% compound annual growth rate (CAGR), from $572.21M to $800.13M.
What does general surgery — net sales mean?
This metric represents the total revenue generated from the sale of medical devices and equipment specifically within the general surgery product category. It reflects the market demand and commercial performance of the firm's non-orthopedic surgical portfolio. Monitoring this figure helps investors assess the growth trajectory and competitive positioning of the company's general surgery business unit.

Ask your AI about CONMED's general surgery — net sales.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude